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Objectives: To comparatively analyze maternal and fetal factors and quality markers of blood
samples in a public umbilical cord blood bank.
Method: This is a cross-sectional descriptive study that revisited 458 records of donations
from September 2009 to March 2013 at the Hemocentro de Santa Catarina. The means of
markers were used to deﬁne cutoff points for the quality of cord blood.
Results: Most donations came from women with ages between 18 and 29 years (62.8%),
gestational age ≥ 40 weeks (55.2%), vaginal delivery (51.3%), primiparous (41.4%), and with
male newborns (54.4%) weighing between 3000 and 3499 g (41.8%). The volume of the dona-
tions  ranged from 71.6 to 275.2 mL, the total nucleated cell count ranged from 4.77 × 108 to
31.0  × 108 cells and CD34+ cells ranged from 0.05 to 1.23%. There were statistically signiﬁcant
differences in the volume with respect to gestation age > 38 weeks (p-value = 0.001), cesarean
section (p-value < 0.001) and birth weight > 3500 g (p-value < 0.001). The total nucleated cell
count  was positively affected by cesarean section (p-value = 0.022) and birth weight > 3500 g
(p-value < 0.001). There was no statistically signiﬁcant difference between the variables and
the percentage of CD34+ cells.
Conclusions: Delivery route and birth weight inﬂuence the volume of cord blood and the total
nucleated cell count. Gestational age inﬂuences only the volume of cord blood.©  2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.Introduction
Umbilical cord blood, which previously used to be discarded,
can be collected shortly after birth and has great capacity to
1reconstitute the hematopoietic system. Several studies have
shown the simplicity of umbilical cord blood collection, in
addition to the lack of risk for both mother and newborn, low
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reserved.risk of graft-versus-host disease and low risk of transmitting
infectious-contagious diseases.2,3 Furthermore, it is a useful
alternative of hematopoietic stem cells for transplantation to
treat diseases of the blood, immune system and for genetic
disorders.3,4 Pedra Branca, 88137-270 Palhoc¸a, SC, Brazil.
One of the limitations of this type of transplant is the
volume and contents of the blood collected from the umbil-
ical cord which is an obstacle to hematopoietic stem cell
 e Terapia Celular. Published by Elsevier Editora Ltda. All rights
oter. 
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rafting. The main parameters used in umbilical cord blood
anks include the total nucleated cell (TNC) count, percentage
f CD34+ cells, and the volume of blood.5
Transplantations using umbilical cord blood are still in the
esearch phase and variables that might improve the quality of
lood are currently the focus of research, inasmuch as know-
ng these factors may result in lower costs and less waste of
ime in the evaluation, processing and storage of material.6,7
Recent studies report that some variables affect the quality
f the umbilical cord blood, especially those related to mater-
al and fetal features such as placental weight, birth weight,
estational age (GA), route of delivery, gender of the newborn,
mong other things; thus research is being developed in this
rea to attempt to improve cell levels, which is essential to
ncrease grafting success rates.
bjectives
he aims of this study were to determine maternal and fetal
haracteristics of umbilical cord blood donors, to evaluate
uality markers of umbilical cord blood, as well as to deter-
ine associations between maternal and fetal characteristics
nd these quality markers.
ethods
his is an observational, cross-sectional, epidemiological
tudy that revisited 458 charts of patients who, between
eptember 2009 and March 2013, donated umbilical cord blood
t the Blood Umbilical Cord and Placental Bank (BSCUP) of the
emocentro de Santa Catarina (HEMOSC), located in the city
f São José, Santa Catarina. Nine medical records of patients
ho  performed allogeneic donations were excluded. Data col-
ection began after the study was approved by the Research
thics Committee of HEMOSC, and data were collected from
omputerized registers in the Cryobiology Sector of HEMOSC,
ocated in Florianópolis, Santa Catarina.
Donation candidates were submitted to the standard sur-
ey of HEMOSC before collection in order to assess personal
istory, family history, and laboratory results with standard
uestions used for all kinds of blood donation. All patients
ho  agreed to donate signed an informed consent form before
he collection.
A data collection instrument was developed exclusively for
his study which investigated the maternal age, gestational
ge, route of delivery, number of previous pregnancies, gen-
er and newborn weight. Moreover, the preprocessing (blood
olume) and post-processing data (TNC and CD34+ counts) of
he umbilical cord blood were studied. The means of markers
ere used to deﬁne cutoff points for the quality of cord blood.
Blood collection was performed extra-utero and carried
ut by a trained professional in a separate room. As soon as
lacental delivery occurs, the placenta is taken to an area
eserved for collection where the umbilical cord is cleaned
ith an antiseptic solution and the blood is drained by gravity
hrough the most distal puncture site. The blood is stored in
 standard blood bag containing citrate-phosphate-dextrose
nticoagulant.2 0 1 5;3 7(1):38–42 39
Once collected, these samples are labeled and sent to blood
banks, where they undergo safety testing, HLA typing and
cryopreservation. Typically, collections are kept for a time not
exceeding 24–28 h at 22 ± 2 ◦C before processing, and then
cryopreserved in liquid nitrogen, under controlled freezing
rates and stored long term in accordance with international
criteria at a temperature lower than −150 ◦C.1,8,9 The umbil-
ical cord blood was processed within a maximum of 48 h
after being collected as is determined by the National Health
Surveillance Agency (ANVISA).2
Collected data were stored in the Microsoft Excel computer
program and later exported to the Statistical Package for the
Social Sciences (Version 16.0) for analysis.
Qualitative variables are described as absolute and rela-
tive frequencies, while quantitative variables are described as
means ± standard deviations.
The Chi-squared test (2) or Fisher’s exact test was used
to test the homogeneity of proportions. Prevalence ratios (PR)
and 95% conﬁdence intervals (95% CI) were calculated. The
level of signiﬁcance was set for a p-value <0.05.
Results
Most donations came from women with ages from 18 to 29
years (62.8%) and from 30 to 34 years (24.4%), gestational
age ≥ 40 weeks (55.2%), vaginal delivery (51.3%), primiparous
(41.4%), and with male newborns (54.4%) weighing between
3000 and 3499 g (41.8%).
Comparisons between maternal and fetal characteristics
and cord blood volume are shown in Table 1.
Statistically signiﬁcant differences were found in respect
to cord blood volume for gestational age > 38 weeks (p-
value = 0.001), cesarean delivery (p-value < 0.001) and birth
weight > 3500 g (p-value < 0.001).
A smaller volume of umbilical cord blood was collected
when the gestational age was below 37 weeks and 6 days com-
pared with gestational ages between 38 and 39 weeks and 6
days. Vaginal route of delivery was associated with a smaller
volume of cord blood when compared to cesarean delivery.
Newborn weight between 2500 and 3499 g was associated with
lower volume of umbilical cord blood when compared with
infants weighing 4000–4999 g. The prevalence of lower volume
was approximately two times higher than the reference value.
The comparison between maternal and fetal characteris-
tics and TNC count is presented in Table 2.
Vaginal route of delivery was associated with a lower TNC
count than cesarean delivery. Birth weights between 2500 and
3499 g were associated with lower TNC counts compared to
those between 4000 and 4499 g, which were at least 2.4 times
greater.
There were no statistically signiﬁcant differences between
quality markers – blood volume, TNC count and percentage of
CD34+.
DiscussionCord blood is increasingly emerging as an alternative source
of stem cells to the bone marrow for transplants, as it has a
good number of hematopoietic progenitor cells with potential
40  rev bras hematol hemoter. 2 0 1 5;3 7(1):38–42
Table 1 – Maternal and fetal characteristics and cord blood volume.
Variable Volume (mL) p-Value PR (95% CI)
≤115.20 >115.20 Total
n (%) n (%) n (%)
GA 0.001
36 to 37/6 weeks 24 (92.3) 2 (7.7) 26 (6.0) 1.70 (1.08–2.67)
38 to 39/6 weeks 90 (54.2) 76 (45.8) 166 (38.8) 1.0
≥40 weeks 132 (55.9) 104 (44.1) 236 (55.2) 1.03 (0.79–1.35)
Delivery route <0.001
Cesarean 107 (49.1) 111 (50.9) 218 (48.7) 1.0
Vaginal 151 (65.7) 79 (34.3) 230 (51.3) 1.34 (1.04–1.71)
Birth weight <0.001
2000–2499 g 3 (75.0) 1 (25.0) 4 (0.9) 2.39 (0.69–8.20)
2500–2999 g 46 (88.5) 6 (11.5) 52 (11.6) 2.82 (1.60–4.98)
3000–3499 g 121 (64.7) 66 (35.3) 187 (41.8) 2.06 (1.22–3.47)
3500–3999 g 71 (49.3) 73 (50.7) 144 (32.1) 1.57 (0.91–2.70)
4000–4499 g 16 (31.4) 35 (68.6) 51 (11.4) 1.0
≥4500 g 1 (10.0) 9 (90.0) 10 (2.2) 0.32 (0.04–2.40)
rval.GA: gestational age; PR: prevalence ratio; 95% CI: 95% conﬁdence inte
for reconstitution. These cells are essential for the treatment
of some hematologic neoplasias.
In this analysis, other factors considered important, such
as alcohol intake and smoking during pregnancy were not
studied because this information did not exist in the patient’s
records.
In this study, vaginal route was the most common form
of delivery, similar to the study by Rosenau et al.4 that inves-
tigated 1549 units of umbilical cord blood, of which 75.27%
were collected after vaginal delivery; again similar to this
study 52.03% of the newborns were male.4 According to Omori
et al.,10 69.8% of the donors were primiparous. This fact might
indicate a tendency of young people to donate umbilical cord
blood as most of these women were young and 41.4% had no
other child. This proves the importance of further research
involving umbilical cord blood and the factors that inﬂuence
the quality.
The mean birth weight of the newborn, according to a
retrospective analysis by Mancinelli et al.,11 was 3390 g and
therefore similar to this study.
Table 2 – Maternal and fetal characteristics and total nucleated 
Variable TNC count (×108 cells) 
≤9.33 >9.33 
n (%) n (%) 
Delivery route (n = 370) 
Cesarean 85 (44.0) 108 (56.0) 
Vaginal 99 (55.9) 78 (44.1) 
Birth weight (n = 371) 
2000–2499 g 2(100) – 
2500–2999 g 25 (80.6) 6 (19.4) 
3000–3499 g 91 (58.7) 64 (41.3) 
3500–3999 g 54 (43.2) 71 (56.8) 
4000–4499 g 12 (24.5) 37 (75.5) 
≥4500 g 1 (11.1) 8 (88.9) 
TNC: total nucleated cell; PR: prevalence ratio; 95% CI: 95% conﬁdence inteAccording to the results, the gestational age only positively
inﬂuenced the volume of blood; the greater the gestational
age, the larger the volume of umbilical cord blood. Askari
et al., in order to demonstrate which variables affect the three
main quality parameters of umbilical cord blood, showed that
a gestational age of over 40 weeks was a predictor for a larger
volume of blood, similar to the current study.6 Shu-Hui Wen
et al. demonstrated that gestational age was inversely propor-
tional to the volume.4 Along with increasing gestational age,
there is a physiological placental senescence, especially from
36 weeks of gestation onwards. This placental aging creates
a reduced oxygen supply to the fetus, releasing vasoconstric-
tor substances that, on reaching the placenta, could reﬂect
in a reduced blood volume available for collection at birth.
In this study no signiﬁcant differences were found between
gestational age and other quality parameters (TNC and CD34+cell counts). However, some authors found a positive relation-
ship between gestational age and the CD34+ cell count.12–15
This information casts doubt on the hypothesis that placen-
tal aging and consequent reduction in blood supply to the
cell count.
p-Value PR (95% CI)
Total
n (%)
0.022
193 (52.2) 1
177 (47.8) 1.27 (1.03–1.56)
<0.001
2 (0.5) 4.08 (0.91–18.24)
31 (8.4) 3.29 (1.65–6.55)
155 (41.8) 2.40 (1.31–4.38)
125 (33.7) 1.76 (0.94–3.29)
49 (13.2) 1
9 (2.4) 0.45 (0.05–3.49)
rval.
oter. 
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etus could provide smaller numbers of umbilical cord blood
ematopoietic cells. Some authors believe that with advanc-
ng gestational age and consequently with placental aging,
he fetus would become progressively hypoxic, resulting in
efense mechanisms. These mechanisms would be respon-
ible for the increases in the number of hematopoietic cells in
mbilical cord blood.11
When the route of delivery was analyzed, it was seen
hat cesarean section was associated with higher TNC counts
nd greater blood volumes. This result has been reported by
everal studies.5,11,13,14,16 However, other authors associated
aginal delivery with higher TNC counts.4,5,17 One hypothesis
or cesarean sections being responsible for a greater volume
f blood collected from the umbilical cord blood is the fact
hat the newborn is placed above the placenta before cord
lamping, possibly causing a downward ﬂow of blood into the
mbilical cord and consequently into the placental compart-
ent. Another hypothesis is that cesarean delivery permits a
ast manual extraction of the placenta thereby reducing the
hance of blood clot formation.11
As expected, the weight of the newborn at birth pre-
ented a positive relationship with two laboratory parameters
nalyzed: the TNC count and blood volume. In this study, sig-
iﬁcantly higher TNC counts and volumes were associated
ith birth weights above 3500 g. To reinforce these ﬁndings,
ther studies reported that greater birth weight positively
nﬂuenced these parameters.5,11,12,17,18 Mancinelli et al., in
rder to determine which obstetrics factors inﬂuence the qual-
ty of umbilical cord blood, showed that a higher birth weight
as associated with better quality of umbilical cord blood in
elation to the three main variables: TNC and CD34+ counts
nd the blood volume.11 Other authors also reported that
his factor was associated with increased CD34+ counts4,13,19;
his was not conﬁrmed in the current study. Thus the greater
irth weight, with a consequent increase in placental volume,
omehow leads to increased blood volume in the placenta.
owever, unlike the results in the literature, this reasoning
oes not explain the correlation between placental volume
ccording to birth weight and the number of CD34+ cells.
Possibly, the determinant of the quality of the stem cells
ill be deﬁned after their use in patients and will thus be
valuated in the clinical practice. The increasing applicabil-
ty and development of technology should serve to highlight
he results found in this study and in many  other studies that
eal with this subject.
onclusions
 gestational age greater than or equal to 38 weeks, cesarean
elivery and birth weight greater than or equal to 3500 g posi-
ively inﬂuence the blood volume collected from the umbilical
ord. Cesarean delivery and birth weight greater than or equal
o 3500 g also have positive correlations with the TNC count.
one of the maternal-fetal characteristics interfere with the
D34+ cell count.onﬂicts  of  interest
he authors declare no conﬂicts of interest.
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